| 724.800 -28.400 (-3.77%) 12-15 17:29 |
|
| Open: | 710.000 |
| High: | 726.600 |
| Low: | 680.000 |
| Pre. close: | 753.200 |
| Volume: | 86,614 |
| Avg. volume: | 104,451 |
| MA (50): | 743.940 |
| MA (200): | 592.504 |
| Year high: | 810.000 |
| Year low: | 456.600 |
| Market cap: | 44,334(M) |
| EPS: | 19.88 |
| PE ratio: | 36.46 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Mon, 15 Dec 2025
Argenx Se: Strategic Focus and Growth Potential in Graves’ Disease Treatment Justifies Buy Rating - TipRanks
Mon, 15 Dec 2025
Argenx stock rating maintained at Buy by BofA despite TED trial failure - Investing.com
Mon, 15 Dec 2025
argenx stock rating reiterated at Buy by Guggenheim despite TED study halt - Investing.com
Mon, 15 Dec 2025
Argenx discontinues phase 3 UplighTED trials of efgartigimod SC in thyroid eye disease - Ophthalmology Times
Mon, 15 Dec 2025
DAY BY DAY Maintains argenx SE - Depositary Receipt (ARGX) Buy Recommendation - Nasdaq
Mon, 15 Dec 2025
Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit - Benzinga
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.